Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Other Non-Current Assets (2019 - 2023)

Historic Other Non-Current Assets for Cyclerion Therapeutics (CYCN) over the last 5 years, with Q2 2023 value amounting to $1.9 million.

  • Cyclerion Therapeutics' Other Non-Current Assets fell 1641.19% to $1.9 million in Q2 2023 from the same period last year, while for Jun 2023 it was $1.9 million, marking a year-over-year decrease of 1641.19%. This contributed to the annual value of $2.0 million for FY2022, which is 1520.57% down from last year.
  • According to the latest figures from Q2 2023, Cyclerion Therapeutics' Other Non-Current Assets is $1.9 million, which was down 1641.19% from $2.0 million recorded in Q1 2023.
  • Cyclerion Therapeutics' 5-year Other Non-Current Assets high stood at $7.7 million for Q2 2019, and its period low was $19000.0 during Q1 2019.
  • Moreover, its 5-year median value for Other Non-Current Assets was $2.5 million (2021), whereas its average is $3.4 million.
  • Within the past 5 years, the most significant YoY rise in Cyclerion Therapeutics' Other Non-Current Assets was 2616842.11% (2020), while the steepest drop was 5033.65% (2020).
  • Over the past 5 years, Cyclerion Therapeutics' Other Non-Current Assets (Quarter) stood at $5.0 million in 2019, then fell by 23.12% to $3.8 million in 2020, then tumbled by 37.27% to $2.4 million in 2021, then dropped by 15.21% to $2.0 million in 2022, then dropped by 8.92% to $1.9 million in 2023.
  • Its Other Non-Current Assets was $1.9 million in Q2 2023, compared to $2.0 million in Q1 2023 and $2.0 million in Q4 2022.